eMed, LLC Sustainability Profile
eMed, LLC, headquartered in the United States, is a pioneering leader in the digital health industry, specialising in at-home diagnostic testing solutions. Founded in 2020, eMed has rapidly established itself as a key player in the healthcare sector, particularly in the realms of telehealth and remote patient monitoring. The company offers a unique suite of products, including its innovative eMed Test Kit, which enables users to conduct tests from the comfort of their homes while ensuring accurate results and seamless integration with telehealth services. eMed's commitment to enhancing patient accessibility and convenience has positioned it as a trusted name in the market. With a focus on improving health outcomes and streamlining the testing process, eMed has achieved significant milestones, including partnerships with major healthcare providers and a growing presence across various operational regions in the US.
DitchCarbon Score
How does eMed, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
eMed, LLC's score of 22 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
eMed, LLC's reported carbon emissions
In 2022, eMed, LLC reported total carbon emissions of approximately 13,627,000 kg CO2e, with Scope 1 emissions accounting for about 13,627,000 kg CO2e, Scope 2 emissions at approximately 134,900 kg CO2e, and Scope 3 emissions around 41,100 kg CO2e. This data reflects a significant increase from 2021, when total emissions were about 5,497,100 kg CO2e, primarily driven by Scope 1 emissions of approximately 5,458,500 kg CO2e. Globally, eMed's emissions for 2022 included about 9,800,000,000 kg CO2e in Scope 1, 700,000,000 kg CO2e in Scope 2, and approximately 4,107,233.4 kg CO2e in Scope 3. This represents a notable increase from 2021, where global emissions were reported at approximately 10,500,000,000 kg CO2e for Scope 1, 800,000,000 kg CO2e for Scope 2, and around 24,648,205.6 kg CO2e for Scope 3. Despite these figures, eMed, LLC has not established specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. The emissions data is not cascaded from any parent organisation, indicating that eMed, LLC is independently reporting its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 11,100,000,000 | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 |
| Scope 2 | 1,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000.0 | 00,000,000.0 | 0,000,000.0 |
How Carbon Intensive is eMed, LLC's Industry?
How Carbon Intensive is eMed, LLC's Location?
eMed, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
eMed, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
